Nirsevimab Injection Cuts RSV-Linked Infections in Preemies
Maternal RSV fusion protein nanoparticle vaccine did not meet prespecified success criterion for efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.